SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000921895-09-000729
Filing Date
2009-03-12
Accepted
2009-03-12 17:05:09
Documents
6
Effectiveness Date
2009-03-12

Document Format Files

Seq Description Document Type Size
1 dfan14a07422003_03122009.htm DFAN14A 64569
2 contact.jpg GRAPHIC 31783
3 chart1and2.jpg GRAPHIC 53791
4 chart3.jpg GRAPHIC 28636
5 chart4.jpg GRAPHIC 26638
6 chart5.jpg GRAPHIC 29258
  Complete submission text file 0000921895-09-000729.txt   301509
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A
SIC: 6282 Investment Advice

Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Subject) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1121
Type: DFAN14A | Act: 34 | File No.: 000-28272 | Film No.: 09676504
SIC: 2835 In Vitro & In Vivo Diagnostic Substances